JEMPERLI 500 MG CONCENTRADO PARA SOLUCION PARA PERFUSION

Glaxosmithkline (Ireland) Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 172b02a2e1b5693e
Drug Cima Aemps Name: JEMPERLI 500 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1211538001IP
Holder Company Name: Glaxosmithkline (Ireland) Limited
Marketing Company Name: Abacus Medicine A/S
Holder Company Detail Path: /organization/glaxosmithkline-ireland-limited
Authorization Date: 2025-08-08
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 500 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Glaxosmithkline (Ireland) Limited
Company Detail Path: /organization/glaxosmithkline-ireland-limited

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Aug 8, 2025

Approval ID

172b02a2e1b5693e

Type

Standard